# BrightSpire Capital, Inc.: financial statements, quarterly

BRSP · NYSE · CIK 1717547 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/brsp.md) · [Financials](/companies/brsp/financials.md) · [Filings](/companies/brsp/filings.md) · [Insiders](/companies/brsp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/brsp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [103 d](/filings/0001717547-26-000008.md) | [95.8](/filings/0001717547-25-000048.md) | [91.4](/filings/0001717547-25-000071.md) | [88.2](/filings/0001717547-25-000083.md) | [83.5 d](/filings/0001717547-26-000008.md) | [77.6](/filings/0001717547-26-000041.md) | [85.9](/filings/0001717547-26-000062.md) | [83.9](/filings/0001717547-26-000076.md) | [83.2 d](/filings/0001717547-26-000008.md) | [85.1](/filings/0001717547-26-000041.md) | [83.5](/filings/0001717547-26-000062.md) | [87.4](/filings/0001717547-26-000076.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [42.9 d](/filings/0001717547-24-000008.md) | [40.1](/filings/0001717547-24-000044.md) | [38.1](/filings/0001717547-24-000072.md) | [38.9](/filings/0001717547-24-000089.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2 d](/filings/0001717547-26-000008.md) | [0.3](/filings/0001717547-25-000048.md) | [0.2](/filings/0001717547-25-000071.md) | [0.2](/filings/0001717547-25-000083.md) | [0.4 d](/filings/0001717547-26-000008.md) | [0.3](/filings/0001717547-26-000041.md) | [(21.7)](/filings/0001717547-26-000062.md) | [(0.1)](/filings/0001717547-26-000076.md) | [0.0 d](/filings/0001717547-26-000008.md) | [0.1](/filings/0001717547-26-000041.md) | [0.0](/filings/0001717547-26-000062.md) | [(0.0)](/filings/0001717547-26-000076.md) |
| Net income | $m | [(16.3) d](/filings/0001717547-26-000008.md) | [(57.1)](/filings/0001717547-25-000048.md) | [(67.9)](/filings/0001717547-25-000071.md) | [12.7](/filings/0001717547-25-000083.md) | [(19.7) d](/filings/0001717547-26-000008.md) | [5.3](/filings/0001717547-26-000041.md) | [(23.1)](/filings/0001717547-26-000062.md) | [1.0](/filings/0001717547-26-000076.md) | [(14.4) d](/filings/0001717547-26-000008.md) | [4.8](/filings/0001717547-26-000041.md) | [(18.3)](/filings/0001717547-26-000062.md) | [46.9](/filings/0001717547-26-000076.md) |
| Diluted EPS | $ per share | not reported | [(0.45)](/filings/0001717547-25-000048.md) | [(0.53)](/filings/0001717547-25-000071.md) | [0.09](/filings/0001717547-25-000083.md) | not reported | [0.04](/filings/0001717547-26-000041.md) | [(0.19)](/filings/0001717547-26-000062.md) | [0.00](/filings/0001717547-26-000076.md) | not reported | [0.03](/filings/0001717547-26-000041.md) | [(0.15)](/filings/0001717547-26-000062.md) | [0.37](/filings/0001717547-26-000076.md) |
| Basic EPS | $ per share | not reported | [(0.45)](/filings/0001717547-25-000048.md) | [(0.53)](/filings/0001717547-25-000071.md) | [0.10](/filings/0001717547-25-000083.md) | not reported | [0.04](/filings/0001717547-26-000041.md) | [(0.19)](/filings/0001717547-26-000062.md) | [0.00](/filings/0001717547-26-000076.md) | not reported | [0.03](/filings/0001717547-26-000041.md) | [(0.15)](/filings/0001717547-26-000062.md) | [0.37](/filings/0001717547-26-000076.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [258](/filings/0001717547-26-000008.md) | [222](/filings/0001717547-25-000048.md) | [203](/filings/0001717547-25-000071.md) | [264](/filings/0001717547-25-000083.md) | [302](/filings/0001717547-26-000076.md) | [201](/filings/0001717547-26-000041.md) | [154](/filings/0001717547-26-000062.md) | [113](/filings/0001717547-26-000076.md) | [66.8](/filings/0001717547-26-000076.md) | [96.6](/filings/0001717547-26-000041.md) | [68.2](/filings/0001717547-26-000062.md) | [63.6](/filings/0001717547-26-000076.md) |
| Total assets | $m | [4,198](/filings/0001717547-25-000008.md) | [3,947](/filings/0001717547-24-000044.md) | [3,778](/filings/0001717547-24-000072.md) | [3,838](/filings/0001717547-24-000089.md) | [3,723](/filings/0001717547-26-000008.md) | [3,551](/filings/0001717547-25-000048.md) | [3,409](/filings/0001717547-25-000071.md) | [3,304](/filings/0001717547-25-000083.md) | [3,565](/filings/0001717547-26-000076.md) | [3,648](/filings/0001717547-26-000041.md) | [3,748](/filings/0001717547-26-000062.md) | [3,668](/filings/0001717547-26-000076.md) |
| Total liabilities | $m | [2,920](/filings/0001717547-25-000008.md) | [2,757](/filings/0001717547-24-000044.md) | [2,679](/filings/0001717547-24-000072.md) | [2,752](/filings/0001717547-24-000089.md) | [2,678](/filings/0001717547-26-000008.md) | [2,520](/filings/0001717547-25-000048.md) | [2,421](/filings/0001717547-25-000071.md) | [2,336](/filings/0001717547-25-000083.md) | [2,636](/filings/0001717547-26-000076.md) | [2,742](/filings/0001717547-26-000041.md) | [2,898](/filings/0001717547-26-000062.md) | [2,798](/filings/0001717547-26-000076.md) |
| Long-term debt | $m | [2,716](/filings/0001717547-25-000008.md) | [2,577](/filings/0001717547-24-000044.md) | [2,503](/filings/0001717547-24-000072.md) | [2,570](/filings/0001717547-24-000089.md) | [2,491](/filings/0001717547-26-000008.md) | [2,344](/filings/0001717547-25-000048.md) | [2,255](/filings/0001717547-25-000071.md) | [2,171](/filings/0001717547-25-000083.md) | [2,469](/filings/0001717547-26-000076.md) | [2,592](/filings/0001717547-26-000041.md) | [2,746](/filings/0001717547-26-000062.md) | [2,634](/filings/0001717547-26-000076.md) |
| Shareholders' equity | $m | [1,277](/filings/0001717547-25-000008.md) | [1,189](/filings/0001717547-24-000044.md) | [1,099](/filings/0001717547-24-000072.md) | [1,088](/filings/0001717547-24-000089.md) | [1,048](/filings/0001717547-26-000008.md) | [1,035](/filings/0001717547-25-000048.md) | [994](/filings/0001717547-25-000071.md) | [976](/filings/0001717547-25-000083.md) | [938](/filings/0001717547-26-000076.md) | [918](/filings/0001717547-26-000041.md) | [863](/filings/0001717547-26-000062.md) | [883](/filings/0001717547-26-000076.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [36.4 d](/filings/0001717547-26-000008.md) | [24.6](/filings/0001717547-25-000048.md) | [22.9 d](/filings/0001717547-25-000071.md) | [31.3 d](/filings/0001717547-25-000083.md) | [24.7 d](/filings/0001717547-26-000008.md) | [10.5](/filings/0001717547-26-000041.md) | [17.4 d](/filings/0001717547-26-000062.md) | [29.9 d](/filings/0001717547-26-000076.md) | [15.2 d](/filings/0001717547-26-000008.md) | [10.9](/filings/0001717547-26-000041.md) | [29.4 d](/filings/0001717547-26-000062.md) | [16.6 d](/filings/0001717547-26-000076.md) |
| Dividends paid | $m | [26.0 d](/filings/0001717547-26-000008.md) | [26.0](/filings/0001717547-25-000048.md) | [26.0 d](/filings/0001717547-25-000071.md) | [26.2 d](/filings/0001717547-25-000083.md) | [20.8 d](/filings/0001717547-26-000008.md) | [20.7](/filings/0001717547-26-000041.md) | [20.8 d](/filings/0001717547-26-000062.md) | [20.9 d](/filings/0001717547-26-000076.md) | [20.6 d](/filings/0001717547-26-000008.md) | [21.9](/filings/0001717547-26-000041.md) | [20.8 d](/filings/0001717547-26-000062.md) | [20.3 d](/filings/0001717547-26-000076.md) |
| Share repurchases | $m | [0.0 d](/filings/0001717547-26-000008.md) | not reported | not reported | [6.6 d](/filings/0001717547-25-000083.md) | [0.0 d](/filings/0001717547-26-000008.md) | not reported | not reported | [1.0 d](/filings/0001717547-26-000076.md) | [6.0 d](/filings/0001717547-26-000008.md) | not reported | not reported | [9.9 d](/filings/0001717547-26-000076.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [127](/filings/0001717547-24-000044.md) | [127](/filings/0001717547-24-000072.md) | [130](/filings/0001717547-24-000089.md) | [127](/filings/0001717547-25-000048.md) | [128](/filings/0001717547-25-000071.md) | [130](/filings/0001717547-25-000083.md) | [130](/filings/0001717547-26-000041.md) | [127](/filings/0001717547-26-000062.md) | [130](/filings/0001717547-26-000076.md) | [129](/filings/0001717547-26-000041.md) | [127](/filings/0001717547-26-000062.md) | [123](/filings/0001717547-26-000076.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 124,676,733 at 2026-10-27, from the cover of the [10-Q filed 2026-10-28](/filings/0001717547-26-000076.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 12:33 ET. No prices; not investment advice.